950130.KQ
Access Bio, Inc.
KOE · Healthcare · Medical - Diagnostics & Research · US
KRW 1,920.00
−2.04%Year over year
Reported trailing growth
- Revenue
- -68.1%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -30.8%
- Operating cash flow
- -32.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -68.8%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026